PRVA Privia Health Group, Inc.

PRVA financial statements, revenue, balance sheet, cash flow, and SEC filings

CIK: 1759655 Exchange: Nasdaq SIC: 8000 (Services-Health Services)
Showing 3 of 7 annual and 0 of 26 quarterly periods. Full history available with a free account or via API.

▼ Company Profile

Filer Category
Large accelerated filer
Entity Type
Operating
Public Float
$1.75B (Jun 2025)
Industry (SIC)
8000 Services-Health Services
Incorporated
DE
Fiscal Year End
December (1231)
Phone
571-366-8850
EIN
000000000
Headquarters
ARLINGTON, VA, 22203
Public Float History
Market value of shares held by public investors, reported in annual DEI filings.
Former Names: PH Group Parent Corp. (2019–2020)

▼ Key Metrics (TTM)

As of Jun 30, 2026
Financials
Revenue
$2.36B
Net Income
$28.12M
Total Assets
$1.49B
Total Equity
$838.07M
Total Debt
-
Free Cash Flow
-
Ratios
Operating Margin
1.9%
Net Margin
1.2%
Return on Equity
3.4%
Return on Assets
1.9%
Current Ratio
1.62x

▼ FY 2025 Summary Analysis

Annual report ending Dec 31, 2025

Overview and Growth

In fiscal 2025, Privia Health Group, Inc. recorded $2.12B of revenue, net income of $22.92M, and an operating cash inflow of $163.40M. The $2.12B revenue base provides substantial context for the company’s earnings, cash generation, and capital requirements. Compared with $1.74B in fiscal 2024, revenue recorded a 22.3% year-over-year increase. The company reported diluted EPS of $0.18, adding a shareholder-level measure to the absolute income figures considered below. Against diluted EPS of $0.11 in fiscal 2024, the current result was 63.6% higher. The diluted weighted-average share count was 128.89M, linking total earnings with the per-share result received by shareholders. The company employed $1.37B of total assets, the balance-sheet base supporting its current operating and cash-flow results. Asset turnover was 1.55x, relating the company’s annual revenue directly to the total assets reported at the period end.

Profitability

Operations produced $34.23M of income after the reported operating expense base, before the remaining non-operating and tax effects. Relative to revenue, operating income represented 1.6%, showing how efficiently sales converted into operating profit. The bottom-line result was net income of $22.92M, after the operating, financing, tax, and other items recognized for the period. Net margin was 1.1%, meaning that this portion of revenue remained as net income after all recognized expenses. Reported EBITDA totaled $44.14M, adding a pre-interest, tax, depreciation, and amortization perspective to the profitability profile. Pretax income was $43.94M, isolating the reported earnings outcome before the income-tax provision recognized for the fiscal year. Measured against revenue, pretax income equaled 2.1%, adding a pre-tax profitability layer between revenue and net income. The company recognized $14.21M of income tax for the period, completing the transition from pretax income to net income. Relative to pretax income, the tax provision measured 32.3%, quantifying the portion of pre-tax earnings paid in income tax. The relationship between net income and period-end equity was 2.9%, indicating the profitability achieved on book capital. Net income represented 1.7% of period-end assets, placing the company’s bottom-line result against the total resource base employed. The company moved from fiscal 2024 net income of $14.38M to $22.92M, with the current outcome ending above that comparison.

Liquidity and Capital Structure

Total assets were $1.37B, supported by $578.43M of liabilities and $790.94M of shareholder equity. The near-term balance sheet paired $911.00M of current assets with $568.52M of current liabilities at the reporting date. At 1.6x, the current ratio shows that short-term assets were greater than short-term liabilities at period end. Cash and equivalents totaled $479.69M, identifying the most liquid reported component available within the broader current-asset balance. Cash and equivalents represented 84.4% of current liabilities, showing the portion of near-term obligations matched by reported cash alone. The equity-to-assets relationship was 57.8%, placing book capital against the total resource base. The liabilities-to-assets relationship was 42.2%, placing reported obligations against the full positive asset balance. Measured against total assets, cash and equivalents represented 35.0%, a balance-sheet composition measure rather than a liquidity forecast. Compared with $1.14B in fiscal 2024, the current asset base moved 20.6% and finished higher. Reported equity changed 15.7% from $683.45M in fiscal 2024, placing the current capital base higher year over year. The reported cash balance changed 2.3% from $491.15M in fiscal 2024, ending lower year over year.

Cash Flow and Earnings Quality

Cash flow from operations was $163.40M, a reported cash inflow that can be compared directly with net income and capital spending. Against net income, operating cash flow measured 7.13x, showing the relationship between accrual earnings and operating cash.
Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated .
Sources and calculation details

Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.

Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.

Annual (FY)
Quarterly 🔒
Chart 🔒
Annual financial statements for Privia Health Group, Inc.
Metric FY2025 📄 FY2024 📄 FY2023 📄
Income Statement
REVENUE
Revenue $2.12B $1.74B $1.66B
OPERATING EXPENSES
SG&A Expense $138.15M $126.16M $109.59M
Operating Income $34.24M $16.98M $20.65M
NON-OPERATING INCOME / EXPENSE
Other Income/Expense $9.70M $10.89M $8.37M
Pretax Income $43.94M $27.87M $29.02M
Income Tax $14.21M $10.83M $7.99M
Net Income $22.92M $14.39M $23.08M
PER SHARE & SUPPLEMENTAL
Diluted EPS $0.18 $0.11 $0.19
Diluted Shares 128.89M 125.61M 124.69M
EBITDA $44.14M $24.25M $27.18M
Depreciation & Amortization $9.91M $7.27M $6.53M
Balance Sheet
ASSETS
Cash & Equivalents $479.69M $491.15M $389.51M
Accounts Receivable $400.90M $316.18M $290.77M
Other Current Assets $30.41M $27.50M $20.53M
Current Assets $911.00M $834.82M $700.80M
PP&E (Net) $504.00K $1.24M $2.33M
Goodwill $209.84M $141.62M $138.75M
Intangible Assets $215.92M $109.81M $107.63M
Other Noncurrent Assets $21.04M $17.09M $8.58M
Noncurrent Assets $458.38M $300.96M $299.10M
Total Assets $1.37B $1.14B $999.90M
LIABILITIES
Accounts Payable $7.97M $9.76M $7.88M
Other Current Liabilities $55.28M $45.81M $28.90M
Current Liabilities $568.52M $449.15M $386.95M
Other Noncurrent Liabilities $2.58M $153.00K $313.00K
Noncurrent Liabilities $9.92M $3.19M $5.56M
Total Liabilities $578.44M $452.34M $392.51M
EQUITY
Common Stock $1.24M $1.20M $1.18M
Additional Paid-in Capital $892.29M $813.21M $753.87M
Retained Earnings $-156.31M $-179.23M $-193.61M
Total Equity $790.94M $683.45M $607.39M
Total Liabilities & Equity $1.37B $1.14B $999.90M
SUPPLEMENTAL
Shares Outstanding 123.60M 120.31M 118.22M
Check: A − (L + E + NCI) - - -
Cash Flow Statement
Cash from Operations $163.40M $109.28M $80.79M
Capital Expenditures - - $113.00K
Cash from Investing $-181.57M $-11.98M $-42.97M
Cash from Financing $6.70M $4.33M $3.71M
Free Cash Flow - - $80.67M
Beginning Cash (CFS) $491.15M $389.51M -
Net Change in Cash $-11.46M $101.64M -
Effect of FX on Cash - - -
Calculated Ending Cash $479.69M $491.15M -
Cash per BS $479.69M $491.15M $389.51M
Cash scope difference (CFS − BS) - - -
Cash per CFS $479.69M $491.15M $389.51M

Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.

Create Free Account Log In
🔒

Quarterly data and charts require a free account

Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.

▼ Frequently Asked Questions

What is Privia Health Group, Inc.'s annual revenue?

Privia Health Group, Inc. reported $2.36B in revenue for trailing twelve months (ending June 2026). Revenue figures are sourced from the company's annual SEC EDGAR filing.

Is Privia Health Group, Inc. profitable?

Yes. Privia Health Group, Inc. reported $28.12M in net income for trailing twelve months. Profitability data is based on the company's most recent annual report filed with the SEC.